An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care

An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary careAn economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care, Published online: 16 January 2019; doi:10.1038/s41397-019-0070-8An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care

Source: The Pharmacogenomics Journal - January 16, 2019 Category: Drugs & Pharmacology Authors: Reinier L. Sluiter Joost G. E. Janzing Gert Jan van der Wilt Wietske Kievit Martina Teichert Source Type: research